Literature DB >> 25805648

miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation.

Xia Li1, Zheng Ji, Si Li, Ya-Nan Sun, Jia Liu, Ying Liu, Wei Tian, Yun-Tao Zhou, Xiao-Ming Shang.   

Abstract

The miR-146-mediated IL-1 receptor-associated kinase 1 (IRAK-1) feedback circuit has been shown to inhibit inflammatory response in macrophages against lipopolysaccharide (LPS). The aim of this study is to compare the antagonized effects of miR-146a-5p on Porphyromonas gingivalis (P.g) lipolysaccharide (LPS)- and advanced glycation end products (AGEs)-triggered ABCA1 and ABCG1 dysregulation and explore the underlying mechanism. THP-1-derived macrophages transfected with miRNA mimics or not were treated with P.g LPS or AGE-BSA, respectively. The mechanism of endotoxin tolerance was mimicked. miR-146a-5p levels and protein levels of IRAK-1, LXRα/β, ABCA1, and ABCG1 were detected by stem-loop reverse transcription followed by TaqMan PCR analysis and Western blotting. Our results showed that miR-146a-5p levels were significantly increased in macrophages after 24 h of stimulation with high dose of P.g LPS or AGE-BSA. Macrophages transfected with miR-146a-5p mimics attenuated the dysregulation of ABCA1/G1 induced by P.g LPS and AGEs through IRAK-1 downregulation. In low-dose LPS-tolerized cells, elevated miR-146a-5p antagonized the increase of ABCA1, ABCG1, and IRAK-1. However, low-dose AGE-BSA did not increase miR-146a-5p levels. In conclusion, the model of endotoxin tolerance is suitable for the antagonistic effects on the dysregulation of ABCA1/G1 induced by high dose of P.g LPS. Conversely, low-dose AGEs did not induce the model of P.g LPS-mediated tolerance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25805648     DOI: 10.1007/s10753-015-0153-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  41 in total

1.  Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB.

Authors:  Jinghua Liu; Shanchao Zhao; Jing Tang; Zhijie Li; Tianyu Zhong; Yawei Liu; Dengyu Chen; Mingzhe Zhao; Yusheng Li; Xiaowei Gong; Peng Deng; Jiang H Wang; Yong Jiang
Journal:  FEBS J       Date:  2009-07-23       Impact factor: 5.542

Review 2.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

3.  IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity.

Authors:  Caishu Deng; Caius Radu; Asim Diab; May F Tsen; Rehana Hussain; John S Cowdery; Michael K Racke; James A Thomas
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.

Authors:  Alejandro Villarreal; Rolando X Aviles Reyes; Maria Florencia Angelo; Analia G Reines; Alberto Javier Ramos
Journal:  J Neurochem       Date:  2011-02-25       Impact factor: 5.372

6.  Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Authors:  Dietrich B Conze; Chuan-Jin Wu; James A Thomas; Allison Landstrom; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

7.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8.

Authors:  Dipa Bhaumik; Gary K Scott; Shiruyeh Schokrpur; Christopher K Patil; Arturo V Orjalo; Francis Rodier; Gordon J Lithgow; Judith Campisi
Journal:  Aging (Albany NY)       Date:  2009-04       Impact factor: 5.682

8.  TLR2 stimulates ABCA1 expression via PKC-η and PLD2 pathway.

Authors:  Dae-Weon Park; Hyung-Kyoung Lee; Ji Hyo Lyu; Haemin Chin; Sang Wook Kang; Young-Jo Kim; Yoe-Sik Bae; Suk-Hwan Baek
Journal:  Biochem Biophys Res Commun       Date:  2012-12-19       Impact factor: 3.575

9.  Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS.

Authors: 
Journal:  Innate Immun       Date:  2008-04       Impact factor: 2.680

10.  MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state.

Authors:  Reuben Saba; Shantel Gushue; Rhiannon L C H Huzarewich; Kathy Manguiat; Sarah Medina; Catherine Robertson; Stephanie A Booth
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more
  9 in total

1.  miR-146a-5p inhibits TNF-α-induced adipogenesis via targeting insulin receptor in primary porcine adipocytes.

Authors:  Di Wu; Qian-Yun Xi; Xiao Cheng; Tao Dong; Xiao-Tong Zhu; Gang Shu; Li-Na Wang; Qing-Yan Jiang; Yong-Liang Zhang
Journal:  J Lipid Res       Date:  2016-06-20       Impact factor: 5.922

Review 2.  Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia.

Authors:  Stephanie A Amici; Joycelyn Dong; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

3.  Periodontitis, pathogenesis and progression: miRNA-mediated cellular responses to Porphyromonas gingivalis.

Authors:  Ingar Olsen; Sim K Singhrao; Harald Osmundsen
Journal:  J Oral Microbiol       Date:  2017-06-12       Impact factor: 5.474

4.  miR‑146a‑5p suppresses ATP‑binding cassette subfamily G member 1 dysregulation in patients with refractory Mycoplasma pneumoniae via interleukin 1 receptor‑associated kinase 1 downregulation.

Authors:  Hu-Nian Li; Xu Zhao; Yong-Jiu Zha; Fang Du; Jie Liu; Liang Sun
Journal:  Int J Mol Med       Date:  2019-10-22       Impact factor: 4.101

Review 5.  Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy.

Authors:  Su Zhang; Yang Meng; Lian Zhou; Lei Qiu; Heping Wang; Dan Su; Bo Zhang; Kui-Ming Chan; Junhong Han
Journal:  MedComm (2020)       Date:  2022-09-15

6.  MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.

Authors:  Maskomani Silambarasan; Jun Rong Tan; Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Charanjit Kaur; Kandiah Jeyaseelan
Journal:  Int J Mol Sci       Date:  2016-04-07       Impact factor: 5.923

7.  The Effect of Cyanobacterial LPS Antagonist (CyP) on Cytokines and Micro-RNA Expression Induced by Porphyromonas gingivalis LPS.

Authors:  Monica Molteni; Annalisa Bosi; Carlo Rossetti
Journal:  Toxins (Basel)       Date:  2018-07-16       Impact factor: 4.546

Review 8.  Genomic Variants and Multilevel Regulation of ABCA1, ABCG1, and SCARB1 Expression in Atherogenesis.

Authors:  Alexandra V Rozhkova; Veronika G Dmitrieva; Elena V Nosova; Alexander D Dergunov; Svetlana A Limborska; Liudmila V Dergunova
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-02

9.  Long intergenic non-protein coding RNA 960 regulates cancer cell viability, migration and invasion through modulating miR-146a-5p/interleukin 1 receptor associated kinase 1 axis in pancreatic ductal adenocarcinoma.

Authors:  Yaoxing Huang; Qingqing Yan; Danchun Yu; Xiaojuan Sun; Shuman Jiang; Weidong Li; Lin Jia
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.